Cooper C - Search Results

1

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.

Khalid S, Calderon-Larranaga S, Sami A, Hawley S, Judge A, Arden N, Van Staa TP, Cooper C, Abrahamsen B, Javaid MK, Prieto-Alhambra D. Khalid S, et al. Among authors: cooper c. Osteoporos Int. 2022 Jul;33(7):1579-1589. doi: 10.1007/s00198-021-06262-1. Epub 2022 Feb 9. Osteoporos Int. 2022. PMID: 35138412 Free article.

2

Epidemiology and prevention of osteoporosis in urbanized Asian populations.

Lau EM, Cooper C. Lau EM, et al. Among authors: cooper c. Osteoporos Int. 1993;3 Suppl 1:23-6. doi: 10.1007/BF01621856. Osteoporos Int. 1993. PMID: 8461569

3

Rationale and clinical indications for bone density measurements.

Cooper C. Cooper C. Osteoporos Int. 1996;6 Suppl 2:6-8. doi: 10.1007/BF01625233. Osteoporos Int. 1996. PMID: 8883128 Review. No abstract available.

4

Femoral neck bone density and fracture risk.

Cooper C. Cooper C. Osteoporos Int. 1996;6 Suppl 3:24-6. doi: 10.1007/BF01623760. Osteoporos Int. 1996. PMID: 8931042 Review. No abstract available.

5

Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group.

O'Neill TW, Silman AJ, Naves Diaz M, Cooper C, Kanis J, Felsenberg D. O'Neill TW, et al. Among authors: cooper c. Osteoporos Int. 1997;7(1):72-8. doi: 10.1007/BF01623464. Osteoporos Int. 1997. PMID: 9102068

6

Upper gastrointestinal adverse events and cyclical etidronate.

van Staa T, Abenhaim L, Cooper C. van Staa T, et al. Among authors: cooper c. Am J Med. 1997 Dec;103(6):462-7. doi: 10.1016/s0002-9343(97)00242-8. Am J Med. 1997. PMID: 9428828

7

Use of cyclical etidronate and prevention of non-vertebral fractures.

van Staa TP, Abenhaim L, Cooper C. van Staa TP, et al. Among authors: cooper c. Br J Rheumatol. 1998 Jan;37(1):87-94. doi: 10.1093/rheumatology/37.1.87. Br J Rheumatol. 1998. PMID: 9487256 Clinical Trial.

8

Postmarketing surveillance of the safety of cyclic etidronate.

van Staa TP, Leufkens H, Abenhaim L, Cooper C. van Staa TP, et al. Among authors: cooper c. Pharmacotherapy. 1998 Sep-Oct;18(5):1121-8. Pharmacotherapy. 1998. PMID: 9758324

9

Hormone replacement therapy, other reproductive variables and symptomatic hip osteoarthritis in elderly white women: a case-control study.

Dennison EM, Arden NK, Kellingray S, Croft P, Coggon D, Cooper C. Dennison EM, et al. Among authors: cooper c. Br J Rheumatol. 1998 Nov;37(11):1198-202. doi: 10.1093/rheumatology/37.11.1198. Br J Rheumatol. 1998. PMID: 9851269

10

Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group.

Ismail AA, Cooper C, Felsenberg D, Varlow J, Kanis JA, Silman AJ, O'Neill TW. Ismail AA, et al. Among authors: cooper c. Osteoporos Int. 1999;9(3):206-13. doi: 10.1007/s001980050138. Osteoporos Int. 1999. PMID: 10450408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,174 results

Search Page

Filters